CIBC Private Wealth Group LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 503 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Private Wealth Group LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2024$71,594
-34.9%
1,345
-16.7%
0.00%
Q1 2024$110,043
-85.8%
1,614
-87.0%
0.00%
-100.0%
Q4 2023$775,927
+114.9%
12,395
+124.5%
0.00%
+100.0%
Q3 2022$361,000
+7.8%
5,5200.0%0.00%0.0%
Q2 2022$335,000
-3.2%
5,5200.0%0.00%0.0%
Q1 2022$346,000
-18.6%
5,520
-1.6%
0.00%0.0%
Q4 2021$425,000
-33.9%
5,609
-2.4%
0.00%0.0%
Q3 2021$643,000
-75.7%
5,749
-64.8%
0.00%
-83.3%
Q2 2021$2,643,000
-29.6%
16,324
-47.0%
0.01%
-33.3%
Q1 2021$3,754,000
+304.1%
30,805
+407.5%
0.01%
+350.0%
Q4 2020$929,000
+76.3%
6,070
-3.7%
0.00%0.0%
Q3 2020$527,000
+154.6%
6,300
+28.8%
0.00%
+100.0%
Q1 2020$207,000
-22.5%
4,890
+11.4%
0.00%0.0%
Q4 2019$267,000
+1060.9%
4,390
+1040.3%
0.00%
Q2 2018$23,000
-4.2%
385
-26.7%
0.00%
Q1 2018$24,0005250.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders